Analyst Consensus ?
ConsensusBuy41 ratings
Bullish2868.3%
Neutral1229.3%
Bearish12.4%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Veeva Systems Inc. complete analyst coverage
Veeva Systems Inc. (VEEV) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$260.21Previous close
$165Low
$270.37Average
$355High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 21, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Neutral | Neutral | Maintain | Aug 28, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 27, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 27, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 27, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 27, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 27, 2026 |
| Needham | Buy | Buy | Maintain | Aug 27, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 27, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Aug 27, 2026 |
| Guggenheim | Buy | Buy | Maintain | Aug 27, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Aug 27, 2026 |
| Canaccord Genuity | Hold | Hold | Maintain | Aug 27, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Aug 27, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 27, 2026 |
| Baird | Outperform | Outperform | Maintain | Aug 27, 2026 |
| Stifel | Buy | Buy | Maintain | Aug 17, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 17, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jun 4, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Jun 4, 2026 |
| BTIG | Buy | Buy | Maintain | Jun 4, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 20, 2026 |
| Keybanc | Overweight | Downgrade | Dec 12, 2025 | |
| Raymond James | Outperform | Outperform | Maintain | Aug 28, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Mar 6, 2025 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Mar 6, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Dec 6, 2024 |
| Jefferies | Buy | Buy | Maintain | Mar 4, 2024 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | Jun 2, 2023 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Mar 2, 2023 |
| Cowen & Co. | Perform | Market Perform | Maintain | Dec 6, 2022 |
| SVB Leerink | Outperform | Outperform | Maintain | Dec 2, 2022 |
| Stephens& Co. | Equal Weight | Overweight | Downgrade | Jan 6, 2022 |
| FBN Securities | Outperform | Outperform | Maintain | Jul 23, 2020 |
| CFRA | Hold | Hold | Maintain | May 29, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Mar 26, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Mar 4, 2020 |
| DA Davidson | Buy | Buy | Maintain | Aug 28, 2019 |
| Bank of America | Buy | Buy | Maintain | Jun 10, 2019 |
| Deutsche Bank | Hold | Hold | Maintain | May 30, 2019 |
| Leerink Swann | Outperform | Outperform | Maintain | Dec 4, 2018 |
| William Blair | Outperform | Outperform | Maintain | Sep 22, 2014 |
| Pacific Crest | Outperform | Outperform | Maintain | Sep 18, 2014 |
Named analyst price targets
Upside is calculated against the persisted previous close $260.21. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Stan Berenshteyn | $330 | $275.09 | +26.8% | Sep 8, 2026 |
| Truist Financial | Analyst unavailable | $305 | $288.01 | +17.2% | Aug 27, 2026 |
| Raymond James | Analyst unavailable | $330 | $295.78 | +26.8% | Aug 27, 2026 |
| UBS | Analyst unavailable | $325 | $294.74 | +24.9% | Aug 27, 2026 |
| RBC Capital | Analyst unavailable | $325 | $286.68 | +24.9% | Aug 27, 2026 |
| Evercore ISI | Kirk Materne | $250 | $244.69 | -3.9% | Aug 27, 2026 |
| Piper Sandler | Analyst unavailable | $320 | $286.46 | +23.0% | Aug 27, 2026 |
| Stifel Nicolaus | David Grossman | $300 | $294.46 | +15.3% | Aug 27, 2026 |
| Morgan Stanley | Craig Hettenbach | $275 | $244.69 | +5.7% | Aug 27, 2026 |
| BMO Capital | Analyst unavailable | $270 | $244.69 | +3.8% | Aug 27, 2026 |
| Mizuho Securities | Analyst unavailable | $280 | $244.69 | +7.6% | Aug 27, 2026 |
| UBS | Analyst unavailable | $290 | $244.69 | +11.4% | Aug 27, 2026 |
| Guggenheim | Analyst unavailable | $310 | $244.69 | +19.1% | Aug 27, 2026 |
| UBS | Analyst unavailable | $260 | $244.69 | -0.1% | Aug 27, 2026 |
| Robert W. Baird | Analyst unavailable | $300 | $244.69 | +15.3% | Aug 27, 2026 |
| UBS | Analyst unavailable | $320 | $244.69 | +23.0% | Aug 27, 2026 |
| Needham | Ryan MacDonald | $310 | $244.69 | +19.1% | Aug 27, 2026 |
| Barclays | Saket Kalia | $315 | $244.69 | +21.1% | Aug 27, 2026 |
| Jefferies | David Windley | $295 | $244.69 | +13.4% | Aug 27, 2026 |
| Needham | Ryan MacDonald | $270 | $247.9 | +3.8% | Aug 24, 2026 |
| Piper Sandler | Billy Fitzsimmons | $295 | $247.9 | +13.4% | Aug 24, 2026 |
| Guggenheim | Tamjid Chowdhury | $276 | $251 | +6.1% | Aug 20, 2026 |
| Barclays | Analyst unavailable | $275 | $238.34 | +5.7% | Aug 18, 2026 |
| Oppenheimer | Ken Wong | $300 | $243.75 | +15.3% | Aug 17, 2026 |
| Stifel Nicolaus | David Grossman | $275 | $243.75 | +5.7% | Aug 17, 2026 |
| Guggenheim | Analyst unavailable | $232 | $184.55 | -10.8% | Jul 22, 2026 |
| BNP Paribas | Andrew DeGasperi | $285 | $178.66 | +9.5% | Jun 4, 2026 |
| Morgan Stanley | Analyst unavailable | $215 | $178.66 | -17.4% | Jun 4, 2026 |
| BMO Capital | Analyst unavailable | $175 | $178.66 | -32.7% | Jun 4, 2026 |
| Robert W. Baird | Analyst unavailable | $260 | $178.66 | -0.1% | Jun 4, 2026 |
| Canaccord Genuity | David Hynes | $220 | $178.66 | -15.5% | Jun 4, 2026 |
| Mizuho Securities | Steven Valiquette | $270 | $178.66 | +3.8% | Jun 4, 2026 |
| Goldman Sachs | Adam Hotchkiss | $165 | $178.66 | -36.6% | Jun 4, 2026 |
| Wells Fargo | Stan Berenshteyn | $320 | $178.66 | +23.0% | Jun 4, 2026 |
| UBS | Analyst unavailable | $235 | $178.66 | -9.7% | Jun 4, 2026 |
| Evercore ISI | Kirk Materne | $185 | $178.66 | -28.9% | Jun 4, 2026 |
| Stifel Nicolaus | David Grossman | $230 | $178.66 | -11.6% | Jun 4, 2026 |
| Raymond James | Brian Peterson | $225 | $178.66 | -13.5% | Jun 4, 2026 |
| Oppenheimer | Analyst unavailable | $275 | $172.17 | +5.7% | Feb 24, 2026 |
| Morgan Stanley | Analyst unavailable | $205 | $174.11 | -21.2% | Feb 17, 2026 |
| Mizuho Securities | Analyst unavailable | $295 | $190.8 | +13.4% | Feb 4, 2026 |
| Goldman Sachs | Adam Hotchkiss | $215 | $233.21 | -17.4% | Jan 13, 2026 |
| Robert W. Baird | Analyst unavailable | $283 | $243.69 | +8.8% | Jan 8, 2026 |
| Morgan Stanley | Craig Hettenbach | $222 | $244.22 | -14.7% | Dec 4, 2025 |
| Wells Fargo | Stan Berenshteyn | $333 | $235.74 | +28.0% | Nov 25, 2025 |
| Jefferies | David Windley | $330 | $244.06 | +26.8% | Nov 24, 2025 |
| Robert W. Baird | Analyst unavailable | $319 | $270.5 | +22.6% | Nov 21, 2025 |
| UBS | Analyst unavailable | $280 | $270.5 | +7.6% | Nov 21, 2025 |
| Canaccord Genuity | Analyst unavailable | $280 | $270.5 | +7.6% | Nov 21, 2025 |
| Barclays | Analyst unavailable | $305 | $270.5 | +17.2% | Nov 21, 2025 |
| Mizuho Securities | Analyst unavailable | $325 | $272.33 | +24.9% | Aug 29, 2025 |
| Barclays | Analyst unavailable | $325 | $280.05 | +24.9% | Aug 28, 2025 |
| Needham | Analyst unavailable | $355 | $280.07 | +36.4% | Aug 28, 2025 |
| Robert W. Baird | Analyst unavailable | $314 | $279.96 | +20.7% | Aug 28, 2025 |
| Piper Sandler | Brent Bracelin | $355 | $280.32 | +36.4% | Aug 28, 2025 |
| UBS | Analyst unavailable | $310 | $272.33 | +19.1% | Aug 28, 2025 |
| UBS | Analyst unavailable | $297 | $272.33 | +14.1% | Aug 28, 2025 |
| UBS | Analyst unavailable | $340 | $272.33 | +30.7% | Aug 28, 2025 |
| Raymond James | Brian Peterson | $340 | $282.71 | +30.7% | Aug 28, 2025 |
| Stifel Nicolaus | Analyst unavailable | $320 | $272.33 | +23.0% | Aug 28, 2025 |
| Barclays | Saket Kalia | $330 | $272.33 | +26.8% | Aug 28, 2025 |
| Wells Fargo | Analyst unavailable | $326 | $287.77 | +25.3% | Aug 26, 2025 |
| Piper Sandler | Brent Bracelin | $325 | $233 | +24.9% | May 29, 2025 |
| Barclays | Analyst unavailable | $300 | $279.04 | +15.3% | May 29, 2025 |
| UBS | Analyst unavailable | $249 | $235.85 | -4.3% | Mar 20, 2025 |
| UBS | Analyst unavailable | $245 | $236.14 | -5.8% | Mar 6, 2025 |
| Truist Financial | Analyst unavailable | $217 | $236.14 | -16.6% | Mar 6, 2025 |
| Raymond James | Analyst unavailable | $285 | $236.14 | +9.5% | Mar 6, 2025 |
| Goldman Sachs | Gabriela Borges | $200 | $229.07 | -23.1% | Jan 23, 2025 |
| Stephens | Jeff Garro | $280 | $219.67 | +7.6% | Dec 19, 2024 |
| Oppenheimer | Ken Wong | $230 | $213.13 | -11.6% | Sep 20, 2024 |
| Truist Financial | Joe Meares | $207 | $217.08 | -20.4% | Sep 3, 2024 |
| Bank of America Securities | Brad Sills | $240 | $199.35 | -7.8% | Aug 29, 2024 |
| Citigroup | Tyler Radke | $281 | $199.35 | +8.0% | Aug 29, 2024 |
| Citigroup | Tyler Radke | $273 | $198.51 | +4.9% | Aug 27, 2024 |
| UBS | Karl Keirstead | $215 | $199.25 | -17.4% | Aug 26, 2024 |
| BTIG | David Larsen | $240 | $182.89 | -7.8% | Jul 9, 2024 |
| Truist Financial | Joe Meares | $197 | $187.29 | -24.3% | Jun 13, 2024 |
| Stifel Nicolaus | David Grossman | $210 | $194.19 | -19.3% | May 31, 2024 |
| Canaccord Genuity | David Hynes | $210 | $194.19 | -19.3% | May 31, 2024 |
| Needham | Ryan MacDonald | $260 | $194.19 | -0.1% | May 31, 2024 |
| Piper Sandler | Brent Bracelin | $235 | $172.84 | -9.7% | May 31, 2024 |
| Robert W. Baird | Joe Vruwink | $245 | $194.19 | -5.8% | May 31, 2024 |
| RBC Capital | Rishi Jaluria | $250 | $194.19 | -3.9% | May 31, 2024 |
| Evercore ISI | Kirk Materne | $200 | $194.19 | -23.1% | May 31, 2024 |
| Robert W. Baird | Joe Vruwink | $255 | $203.09 | -2.0% | May 29, 2024 |
| Wells Fargo | Stan Berenshteyn | $242 | $203.89 | -7.0% | May 28, 2024 |
| Piper Sandler | Brent Bracelin | $200 | $174.03 | -23.1% | Dec 7, 2023 |
| Barclays | Saket Kalia | $220 | $208.98 | -15.5% | Aug 31, 2023 |
| Oppenheimer | Analyst unavailable | $225 | $165.31 | -13.5% | Jan 12, 2023 |
| Piper Sandler | Analyst unavailable | $204 | $159.61 | -21.6% | Jan 9, 2023 |
| Morgan Stanley | Analyst unavailable | $181 | $161.44 | -30.4% | Jan 6, 2023 |
| UBS | Analyst unavailable | $190 | $162.77 | -27.0% | Dec 20, 2022 |
| Cowen & Co. | Analyst unavailable | $184 | $167.24 | -29.3% | Dec 6, 2022 |
| UBS | Analyst unavailable | $200 | $177.43 | -23.1% | Dec 2, 2022 |
| Raymond James | Analyst unavailable | $215 | $191.42 | -17.4% | Dec 2, 2022 |
| Needham | Analyst unavailable | $220 | $191.42 | -15.5% | Dec 2, 2022 |
| Leerink Partners | Analyst unavailable | $233 | $191.42 | -10.5% | Dec 2, 2022 |
| JMP Securities | Joe Goodwin | $215 | $199.32 | -17.4% | Sep 1, 2022 |
| SVB Securities | Stephanie Davis | $242 | $199.32 | -7.0% | Sep 1, 2022 |
| Guggenheim | Jack Wallace | $252 | $198.04 | -3.2% | Jun 30, 2022 |
| New Street | Gabriela Borges | $253 | $198.43 | -2.8% | Jun 23, 2022 |
| Goldman Sachs | Gabriela Borges | $253 | $187.67 | -2.8% | Jun 23, 2022 |
| JMP Securities | Joe Goodwin | $240 | $187.73 | -7.8% | Jun 10, 2022 |
| Needham | Ryan MacDonald | $205 | $192.55 | -21.2% | Jun 2, 2022 |
| Guggenheim | Kenneth Wong | $255 | $193.16 | -2.0% | Mar 3, 2022 |
| Bank of America Securities | Bradley Sills | $220 | $193.16 | -15.5% | Mar 3, 2022 |
| Stifel Nicolaus | David Grossman | $265 | $193.16 | +1.8% | Mar 3, 2022 |
| Morgan Stanley | Stan Zlotsky | $225 | $193.16 | -13.5% | Mar 3, 2022 |
| UBS | Karl Keirstead | $210 | $193.16 | -19.3% | Mar 3, 2022 |
| Citigroup | Tyler Radke | $278 | $232.05 | +6.8% | Mar 1, 2022 |
| Truist Financial | Joseph Meares | $275 | $224.74 | +5.7% | Jan 28, 2022 |
| Canaccord Genuity | David Hynes | $300 | $291.34 | +15.3% | May 28, 2021 |
| Evercore ISI | Kirk Materne | $313 | $291.34 | +20.3% | May 28, 2021 |
Track every rating change on VEEV the moment it posts. Free to start.
Start freeGet the VEEV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.